120 related articles for article (PubMed ID: 8576216)
21. Structural organization of the fibrin(ogen) alpha C-domain.
Tsurupa G; Tsonev L; Medved L
Biochemistry; 2002 May; 41(20):6449-59. PubMed ID: 12009908
[TBL] [Abstract][Full Text] [Related]
22. Involvement of the alpha chain in fibrin clot formation. Effect of monoclonal antibodies.
Cierniewski CS; Budzynski AZ
Biochemistry; 1992 May; 31(17):4248-53. PubMed ID: 1373653
[TBL] [Abstract][Full Text] [Related]
23. Further studies on the topography of the N-terminal region of human platelet glycoprotein IIIa. Localization of monoclonal antibody epitopes and the putative fibrinogen-binding sites.
Calvete JJ; Arias J; Alvarez MV; Lopez MM; Henschen A; González-Rodríguez J
Biochem J; 1991 Mar; 274 ( Pt 2)(Pt 2):457-63. PubMed ID: 1706596
[TBL] [Abstract][Full Text] [Related]
24. Fibrinogen binds to integrin alpha(5)beta(1) via the carboxyl-terminal RGD site of the Aalpha-chain.
Suehiro K; Mizuguchi J; Nishiyama K; Iwanaga S; Farrell DH; Ohtaki S
J Biochem; 2000 Oct; 128(4):705-10. PubMed ID: 11011154
[TBL] [Abstract][Full Text] [Related]
25. Conformational and structural modulation of the NH2-terminal regions of fibrinogen and fibrin associated with plasmin cleavage.
Edgington TS; Plow EF
J Biol Chem; 1975 May; 250(9):3393-8. PubMed ID: 47328
[TBL] [Abstract][Full Text] [Related]
26. The amino acids that constitute sequence gamma 268-282 of fibrinogen are not involved in fibrin monomer polymerization.
Janiak A; Plucinski T; Kupryszewski G; Cierniewski CS
Acta Biochim Pol; 1993; 40(4):515-20. PubMed ID: 8140826
[TBL] [Abstract][Full Text] [Related]
27. Immunochemical evidence for intramolecular interaction of the carboxy terminal A alpha-appendages of plasma fibrinogen.
Gargan PE; DaMatta RA; Silverman T; Ploplis VA
Blood Coagul Fibrinolysis; 1990 Oct; 1(4-5):457-60. PubMed ID: 1723303
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of coaggregation between Porphyromonas gingivalis and Streptococcus oralis by fibrinogen fragments.
Nagata H; Amano A; Hanioka T; Tamagawa H; Shizukuishi S; Miyata T
FEMS Microbiol Lett; 1993 Nov; 114(1):31-6. PubMed ID: 8293957
[TBL] [Abstract][Full Text] [Related]
29. Immunochemical mapping of alpha-2 interferon.
Lydon NB; Favre C; Bove S; Neyret O; Benureau S; Levine AM; Seelig GF; Nagabhushan TL; Trotta PP
Biochemistry; 1985 Jul; 24(15):4131-41. PubMed ID: 2413884
[TBL] [Abstract][Full Text] [Related]
30. Immunochemical mapping of the conformation of human fibrinogen. The gamma 95-264 segment in inaccessible to antibody in native fibrinogen but progressively exposed by plasmic cleavage.
Fair DS; Edgington TS; Plow EF
J Biol Chem; 1981 Aug; 256(15):8018-23. PubMed ID: 6167572
[TBL] [Abstract][Full Text] [Related]
31. Amino acid sequence of the carboxy-terminal cyanogen bromide peptide of the human fibrinogen beta-chain: homology with the corresponding gamma-chain peptide and presence in fragment D.
Takagi T; Doolittle RF
Biochim Biophys Acta; 1975 Apr; 386(2):617-22. PubMed ID: 124585
[TBL] [Abstract][Full Text] [Related]
32. Human fibrinogen heterogeneity: the COOH-terminal residues of defective A alpha chains of fibrinogen II.
Nakashima A; Sasaki S; Miyazaki K; Miyata T; Iwanaga S
Blood Coagul Fibrinolysis; 1992 Aug; 3(4):361-70. PubMed ID: 1420813
[TBL] [Abstract][Full Text] [Related]
33. Monoclonal antibodies as probes for functional domains in cAMP-dependent protein kinase II.
Weldon SL; Taylor SS
J Biol Chem; 1985 Apr; 260(7):4203-9. PubMed ID: 2579946
[TBL] [Abstract][Full Text] [Related]
34. Internalization of the amino terminal 1-78 sequence of the gamma chain of native fibrinogen and exposure associated with catabolism and plasmin cleavage.
Cierniewski CS; Edgington TS
Biochim Biophys Acta; 1979 Sep; 580(1):32-43. PubMed ID: 94836
[TBL] [Abstract][Full Text] [Related]
35. Further characterization of the thrombasthenia-related idiotype OG. Antiidiotype defines a novel epitope(s) shared by fibrinogen B beta chain, vitronectin, and von Willebrand factor and required for binding to beta 3.
Gruel Y; Brojer E; Nugent DJ; Kunicki TJ
J Exp Med; 1994 Dec; 180(6):2259-67. PubMed ID: 7525851
[TBL] [Abstract][Full Text] [Related]
36. Anti-idiotypic antibodies against an antibody to the platelet glycoprotein (GP) IIb-IIIa complex mimic GP IIb-IIIa by recognizing fibrinogen.
Abrams CS; Ruggeri ZM; Taub R; Hoxie JA; Nagaswami C; Weisel JW; Shattil SJ
J Biol Chem; 1992 Feb; 267(4):2775-85. PubMed ID: 1370832
[TBL] [Abstract][Full Text] [Related]
37. Residence time effects on monoclonal antibody binding to adsorbed fibrinogen.
Horbett TA; Lew KR
J Biomater Sci Polym Ed; 1994; 6(1):15-33. PubMed ID: 7947470
[TBL] [Abstract][Full Text] [Related]
38. Shadow-cast electron microscopy of fibrinogen with antibody fragments bound to specific regions.
Price TM; Strong DD; Rudee ML; Doolittle RF
Proc Natl Acad Sci U S A; 1981 Jan; 78(1):200-4. PubMed ID: 6941244
[TBL] [Abstract][Full Text] [Related]
39. A hamster antibody to the mouse fibrinogen gamma chain inhibits platelet-fibrinogen interactions and FXIIIa-mediated fibrin cross-linking, and facilitates thrombolysis.
Jirousková M; Smyth SS; Kudryk B; Coller BS
Thromb Haemost; 2001 Oct; 86(4):1047-56. PubMed ID: 11686323
[TBL] [Abstract][Full Text] [Related]
40. Use of a synthetic homologue of human fibrinopeptide A for production of a monoclonal antibody specific for the free peptide.
Kudryk B; Gidlund M; Rohoza A; Ahadi M; Coiffe D; Weitz JI
Blood; 1989 Aug; 74(3):1036-44. PubMed ID: 2752151
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
